Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Mathew Lucas has joined Pearce IP after spending more than 25 years at Qantm IP-owned firm Davies Collison Cave
Jennifer Che explains how taking on the managing director role at her firm has offered a new perspective, and why Hong Kong is seeing a life sciences boom
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
The shortlist for our annual Americas Awards will be published next month, with potential winners in more than 90 categories set to be revealed
The four-partner addition includes A&O Shearman’s former co-head of global IP litigation
In the sixth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP Futures, a network for early-career stage IP professionals
Rachel Cohen has reunited with her former colleagues to strengthen Weil’s IP litigation and strategy work
In the fifth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss the ‘Careers in Ideas’ network and how to open access to the profession
Moore & Van Allen hires former Teva counsel Larry Rickles to help expand the firm’s life sciences capabilities
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
Sponsored
Sponsored
-
Sponsored by Bugnion SpAAndrea Delbarba and Claudia Finetti of Bugnion SpA explain how supplementary protection certificates extend pharmaceutical patent protection, the role of paediatric extensions, and recent Italian clarifications on fees and regulatory processes -
Sponsored by Spoor & FisherDavid Cochrane of Spoor & Fisher South Africa explains the key updates under the act, which strengthens breeder protections while supporting vulnerable farmers and aligning with international norms
-
Sponsored by MaiwaldKerstin Wolff of Maiwald Intellectual Property examines the EU’s winding path towards the regulation of new genomic techniques, with a proposed patent ban remaining a key source of contention
-
Sponsored by CASThe emerging trends and strategic approaches in intellectual property search and analytics are outlined in a CAS article that suggests how chemical industry stakeholders can strengthen patent programmes, empower R&D teams, and gain competitive insight
-
Sponsored by Wanhuida Intellectual PropertyWu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations involving active ingredients that are chemically reactive
-
Sponsored by MaiwaldAnnelie Wünsche of Maiwald Intellectual Property summarises the EU’s proposed update to the supplementary protection certificate system for medicinal products, highlighting key procedural shifts, the role of the EUIPO, and ongoing debate over the most suitable examining authority
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Managing partner Mark O’Donnell explains why people are at the centre of the Australian outfit’s investment focus and how being independent benefits the firm
The five-partner team enhances Sheppard Mullin’s technology and life sciences capabilities, expanding its IP practice to more than 130 practitioners
In an exclusive interview, Rouse CEO Luke Minford, Arnold & Siedsma managing partner Steve Duxbury, and Wrays executive chairman Gary Cox discuss plans to build the world’s first ‘truly integrated’ global IP services business
Interviews; Exclusives
Interviews; Exclusives
The firm has added six practitioners in recent weeks as it takes measured steps to build its IP practice with a focus on trade secrets work
Daralyn Durie discusses the ‘amazing’ opportunity of working on an AI case, the value of celebrating women, and how to build the next wave of talent
MBIP principals Andy Mukherji and Ellen Reid discuss the firm’s combination with Jones Tulloch and reveal why younger firms stand to gain from AI demand
A partner who joined Fenwick alongside two others explains what drew her to the firm and her hopes for growth in Boston
Griffith Hack’s Amanda Stark, one of our ‘Top 250 Women in IP’, explains how peer support from male colleagues is crucial, and reveals why the life sciences sector is thriving
The IP team at Morais Leitão discusses high-stakes litigation, strategic partnerships with clients, and bolstering cross-border expertise
-
Weekly take: Why the EU must press ahead with unitary SPCs
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer -
Weekly take: IP-trade demands will fail future generations
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important -
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue -
Opinion: Indian domestic policy must match WTO stand on IP waivers
India has been both urging for vaccine waivers before the WTO and refusing compulsory licensing in the country, but it’s not helping anyone
Michelle Lee discusses reaching milestones at the USPTO, AI’s role in legal work, and how to empower women in tech and IP
João Negrão, EUIPO executive director, is joined by a seasoned official to reflect on three decades of stories
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
In our latest podcast, Deborah Hampton talks through her hopes for the year, INTA’s patent focus, London 2026, and her love of music
In the final episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss the IP Inclusive Charter and the senior leaders’ pledge
In the ninth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP & ME, a community focused on ethnic minority IP professionals
In the eighth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP Ability, a network for disabled people and carers active in the IP profession
In the seventh episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP Out, a network for LGBTQAI+ professionals and their allies
Chris Adamson and Milli Bouri of Adamson & Partners join us to discuss IP market trends and what law firm and in-house clients are looking for
In the sixth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP Futures, a network for early-career stage IP professionals
The LMG Life Sciences Awards announces the 2025 winners for the 13th annual awards!
Practitioners and law firms should keep their eyes peeled as the shortlist for our annual Awards is set to be released